Status:
UNKNOWN
Prevalence of Fibromyalgia in Israel
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Collaborating Sponsors:
Pfizer
Conditions:
Fibromyalgia
Eligibility:
All Genders
18+ years
Brief Summary
The prevalence of fibromyalgia syndrome in the Israeli population is of importance fro planning resource allocation of medical expenditure as well as for identifying demographic and ethnic differences...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Individuals over 18 who consent to answer the survey questions
Exclusion
Key Trial Info
Start Date :
October 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2012
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT01203865
Start Date
October 1 2010
End Date
March 1 2012
Last Update
October 12 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tel Aviv SOurasky Medical center
Tel Aviv, Israel